As pharmaceutical companies, and particularly as developers of innovative medicines, we are important allies of doctors and patients in the fight against diseases. After all, we are the pharmaceutical companies that develop new resources to fight these diseases.
As members of the Association Innovative Medicines, we realise that we are partners in a broader alliance of healthcare professionals, institutions, patient organisations, insurers and government. Only if all partners can trust each other, we can jointly provide the best care to patients.
That trust begins with integrity of conduct. Hence, in this section, we describe the principles of our conduct. These principles are about responsibility, provision of information and fair dealings with healthcare professionals and the public. They are also about the way in which we have organised ourselves to consistently adhere to these principles.
The Platform on Transparency and Ethics has established a list of principles to which we are committed.
In order to specify the core value of integrity, we consider the following:
Openness is an important condition for trust. With regard to our societal mandate as pharmaceutical companies, open and clear communication is needed on how the (societal) interests of those involved are taken into account.
We may be expected to be transparent about our studies conducted during the (further) development of medicinal products, as well as their results and our financial relationships with healthcare professionals and patient organisations.
Furthermore, we play a role in predictability of the availability and affordability of medicines in the Dutch market, as well as the expected healthcare outcomes. A core value for us is to contribute to this transparency and predictability.
In the interpretation of the core value transparency, we consider the following:
We wish to be honest and reliable partners for those with whom we deal directly and wish to have a role in society as a whole. This means, among other things, defending the interests of patients, contributing to the improvement of the environment, providing resources for social projects, and providing a safe and pleasant working environment for employees.
Corporate social responsibility is a broad concept which is interpreted in different ways. International standards exist (incorporated in the ISO 26000) which describe what should be understood under good governance, respect for human rights, provision of good working conditions, environmental responsibility, fair business practices, consumer interests and involvement in the development of the community.
As internationally operating pharmaceutical companies, we embrace and implement these international standards.
In order to implement the core value of Social Responsibility, we consider the following:
As pharmaceutical companies we aim at achieving a high quality of our products and services. Pharmaceutical research and development is subject to strict quality standards and requirements. The requirements set our products, production and services is guaranteed by quality systems. Once a medicine is marketed, we closely monitor its safety.
We continuously monitor the various aspects of quality provided and allocate sufficient resources to improve the product and the process. In addition, we work with supply-chain partners to counteract counterfeit medicines.
In order to contribute to the quality core value, we consider the following:
Google+
Uw naam
Uw e-mail adres
Naam ontvanger
E-mail adres ontvanger
Uw bericht